Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure

被引:147
作者
Hadase, M
Azuma, A
Zen, K
Asada, S
Kawasaki, T
Kamitani, T
Kawasaki, S
Sugihara, H
Matsubara, H
机构
[1] Kyoto Prefectural Univ Med, Dept Cardiol, Kamigyo Ku, Kyoto 6028566, Japan
[2] Matsushita Mem Hosp, Dept Cardiol, Osaka, Japan
关键词
congestive heart failure; heart rate variability; prognosis; very low frequency power;
D O I
10.1253/circj.68.343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The present study examined whether the very low frequency (VLF) power of heart rate variability (HRV) is predictive of clinical prognosis in patients with congestive heart failure (CHF). Method and Results The study recruited 54 consecutive CHF patients with emergency admission because of exacerbation of pulmonary congestion. Holter monitoring was performed after improvement of pulmonary congestion. The frequency components of HRV were calculated in the frequency domain (VLF, low frequency (LF), high frequency (HF), total power (TP) and the ratio of LF to HF power). The left ventricular ejection fraction was calculated, and plasma brain natriuretic peptide (BNP) and norepinephrine were also measured at discharge. Within a mean follow-up period of 19.8+/-11.7 months, 18 patients experienced cardiovascular events; 7 patients died and 11 patients required rehospitalization because of worsening of CHF. In univariate analysis, diabetes mellitus (DM), BNP and New York Heart Association (NYHA) functional class were significant as risk factors for cardiac events. VLF power, LF power and TP were the strong predictors for cardiac events in HRV. In multivariate analysis, VLF power predicted cardiac events independently of LF power, TP, DM, BNP and NYHA functional class (chi-square= 6.24, p=0.01). Conclusions VLF power is an independent risk predictor in patients with CHF.
引用
收藏
页码:343 / 347
页数:5
相关论文
共 39 条
[21]   Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure [J].
Lanfranchi, PA ;
Braghiroli, A ;
Bosimini, E ;
Mazzuero, G ;
Colombo, R ;
Donner, CF ;
Giannuzzi, P .
CIRCULATION, 1999, 99 (11) :1435-1440
[22]   Effects of linear ablation at the isthmus between the tricuspid annulus and inferior vena cava for atrial flutter on autonomic nervous activity - Analysis of heart rate variability [J].
Li, AY ;
Kuga, K ;
Suzuki, A ;
Endo, M ;
Niho, B ;
Enomoto, M ;
Kanemoto, M ;
Yamaguchi, I .
CIRCULATION JOURNAL, 2002, 66 (01) :53-57
[23]   Utility of B-natriuretic peptide in detecting diastolic dysfunction - Comparison with Doppler velocity recordings [J].
Lubien, E ;
DeMaria, A ;
Krishnaswamy, P ;
Clopton, P ;
Koon, J ;
Kazanegra, R ;
Gardetto, N ;
Wanner, E ;
Maisel, AS .
CIRCULATION, 2002, 105 (05) :595-601
[24]   CARDIOVASCULAR NEURAL REGULATION EXPLORED IN THE FREQUENCY-DOMAIN [J].
MALLIANI, A ;
PAGANI, M ;
LOMBARDI, F ;
CERUTTI, S .
CIRCULATION, 1991, 84 (02) :482-492
[25]  
Mortara A, 1997, CIRCULATION, V96, P246
[26]  
Nakazawa K, 2003, CIRC J, V67, P511
[27]   EFFECTS OF NASAL CPAP ON SYMPATHETIC ACTIVITY IN PATIENTS WITH HEART-FAILURE AND CENTRAL SLEEP-APNEA [J].
NAUGHTON, MT ;
BENARD, DC ;
LIU, PP ;
RUTHERFORD, R ;
RANKIN, F ;
BRADLEY, TD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (02) :473-479
[28]   Prospective study of heart rate variability and mortality in chronic heart failure - Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart) [J].
Nolan, J ;
Batin, PD ;
Andrews, R ;
Lindsay, SJ ;
Brooksby, P ;
Mullen, H ;
Baig, W ;
Flapan, AD ;
Cowley, A ;
Prescott, RJ ;
Neilson, JMM ;
Fox, KAA .
CIRCULATION, 1998, 98 (15) :1510-1516
[29]   The effect of carvedilol on morbidity and mortality in patients with chronic heart failure [J].
Packer, M ;
Bristow, MR ;
Cohn, JN ;
Colucci, WS ;
Fowler, MB ;
Gilbert, EM ;
Shusterman, NH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1349-1355
[30]  
PACKER M, 1988, POSTGRAD MED, V83, P96